Skip to main content
Top
Published in: BMC Health Services Research 1/2011

Open Access 01-12-2011 | Research article

Identifying and prioritizing strategies for comprehensive liver cancer control in Asia

Authors: John FP Bridges, Gisselle Gallego, Masatoshi Kudo, Kiwamu Okita, Kwang-Hyub Han, Sheng-Long Ye, Barri M Blauvelt

Published in: BMC Health Services Research | Issue 1/2011

Login to get access

Abstract

Background

Liver cancer is both common and burdensome in Asia. Effective liver cancer control, however, is hindered by a complex etiology and a lack of coordination across clinical disciplines. We sought to identify strategies for inclusion in a comprehensive liver cancer control for Asia and to compare qualitative and quantitative methods for prioritization.

Methods

Qualitative interviews (N = 20) with international liver cancer experts were used to identify strategies using Interpretative Phenomenological Analysis and to formulate an initial prioritization through frequency analysis. Conjoint analysis, a quantitative stated-preference method, was then applied among Asian liver cancer experts (N = 20) who completed 12 choice tasks that divided these strategies into two mutually exclusive and exhaustive subsets. Respondents' preferred plan was the primary outcome in a choice model, estimated using ordinary least squares (OLS) and logistic regression. Priorities were then compared using Spearman's Rho.

Results

Eleven strategies were identified: Access to treatments; Centers of excellence; Clinical education; Measuring social burden; Monitoring of at-risk populations; Multidisciplinary management; National guidelines; Public awareness; Research infrastructure; Risk-assessment and referral; and Transplantation infrastructure. Qualitative frequency analysis indicated that Risk-assessment and referral (85%), National guidelines (80%) and Monitoring of at-risk populations (80%) received the highest priority, while conjoint analysis pointed to Monitoring of at-risk populations (p < 0.001), Centers of excellence (p = 0.002), and Access to treatments (p = 0.004) as priorities, while Risk-assessment and referral was the lowest priority (p = 0.645). We find moderate concordance between the qualitative and quantitative methods (rho = 0.20), albeit insignificant (p = 0.554), and a strong concordance between the OLS and logistic regressions (rho = 0.979; p < 0.0001).

Conclusions

Identified strategies can be conceptualized as the ABCs of comprehensive liver cancer control as they focus on Antecedents, Better care and Connections within a national strategy. Some concordance was found between the qualitative and quantitative methods (e.g. Monitoring of at-risk populations), but substantial differences were also identified (e.g. qualitative methods gave highest priority to risk-assessment and referral, but it was the lowest for the quantitative methods), which may be attributed to differences between the methods and study populations, and potential framing effects in choice tasks. Continued research will provide more generalizable estimates of priorities and account for variation across stakeholders and countries.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D: GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. 2010, Lyon: International Agency for Research on Cancer, [http://globocan.iarc.fr] Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D: GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. 2010, Lyon: International Agency for Research on Cancer, [http://​globocan.​iarc.​fr]
2.
go back to reference Venook AP, Papandreou C, Furuse J, de Guevara LL: The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist. 2010, 15 (Suppl 4): 5-13.CrossRefPubMed Venook AP, Papandreou C, Furuse J, de Guevara LL: The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist. 2010, 15 (Suppl 4): 5-13.CrossRefPubMed
3.
go back to reference Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma: Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements. J Gastroenterol Hepatol. 2010, 25: 657-663.CrossRef Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma: Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements. J Gastroenterol Hepatol. 2010, 25: 657-663.CrossRef
4.
go back to reference Teo EK, Fock KM: Hepatocellular carcinoma: an Asian perspective. Dig Dis. 2001, 19: 263-268. 10.1159/000050692.CrossRefPubMed Teo EK, Fock KM: Hepatocellular carcinoma: an Asian perspective. Dig Dis. 2001, 19: 263-268. 10.1159/000050692.CrossRefPubMed
5.
go back to reference Zhu AX: Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be?. Oncologist. 2006, 11: 790-800. 10.1634/theoncologist.11-7-790.CrossRefPubMed Zhu AX: Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be?. Oncologist. 2006, 11: 790-800. 10.1634/theoncologist.11-7-790.CrossRefPubMed
6.
go back to reference de Villa V, Lo CM: Liver transplantation for hepatocellular carcinoma in Asia. Oncologist. 2007, 12: 1321-1331. 10.1634/theoncologist.12-11-1321.CrossRefPubMed de Villa V, Lo CM: Liver transplantation for hepatocellular carcinoma in Asia. Oncologist. 2007, 12: 1321-1331. 10.1634/theoncologist.12-11-1321.CrossRefPubMed
7.
go back to reference Mitchell AE, Colvin HM, Palmer Beasley R: Institute of Medicine recommendations for the prevention and control of hepatitis B and C. Hepatology. 2010, 51: 729-733. 10.1002/hep.23561.CrossRefPubMed Mitchell AE, Colvin HM, Palmer Beasley R: Institute of Medicine recommendations for the prevention and control of hepatitis B and C. Hepatology. 2010, 51: 729-733. 10.1002/hep.23561.CrossRefPubMed
8.
go back to reference Steger C, Daniel K, Gurian CL, Petherick JT, Stockmyer C, David AM, Miller SE: Public policy action and CCC implementation: benefits and hurdles. Cancer Causes Control. 2010, 21: 2041-2048. 10.1007/s10552-010-9668-5.CrossRefPubMedPubMedCentral Steger C, Daniel K, Gurian CL, Petherick JT, Stockmyer C, David AM, Miller SE: Public policy action and CCC implementation: benefits and hurdles. Cancer Causes Control. 2010, 21: 2041-2048. 10.1007/s10552-010-9668-5.CrossRefPubMedPubMedCentral
9.
go back to reference WHO: National Cancer Control Programs: Policies and managerial guidelines. 2002, Geneva: World Health Organization, 2 WHO: National Cancer Control Programs: Policies and managerial guidelines. 2002, Geneva: World Health Organization, 2
10.
go back to reference Bridges J, Anderson BO, Buzaid AC, Jazieh AR, Niessen L, Blauvelt B, Buchanan D: Identifying Important Breast Cancer Control Strategies in Asia, Latin America and the Middle East/North Africa. BMC Health Serv Res. 2011, 11: 227-10.1186/1472-6963-11-227.CrossRefPubMedPubMedCentral Bridges J, Anderson BO, Buzaid AC, Jazieh AR, Niessen L, Blauvelt B, Buchanan D: Identifying Important Breast Cancer Control Strategies in Asia, Latin America and the Middle East/North Africa. BMC Health Serv Res. 2011, 11: 227-10.1186/1472-6963-11-227.CrossRefPubMedPubMedCentral
11.
go back to reference Chang MH: Cancer prevention by vaccination against hepatitis B. Recent Results. Cancer Res. 2009, 181: 85-94. Chang MH: Cancer prevention by vaccination against hepatitis B. Recent Results. Cancer Res. 2009, 181: 85-94.
12.
go back to reference Tseng PL, Wang JH, Tung HD, Hung CH, Kee KM, Chen CH, et al: Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screening. J Gastroenterol Hepatol. 2010, 25: 1426-1434. 10.1111/j.1440-1746.2010.06285.x.CrossRefPubMed Tseng PL, Wang JH, Tung HD, Hung CH, Kee KM, Chen CH, et al: Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screening. J Gastroenterol Hepatol. 2010, 25: 1426-1434. 10.1111/j.1440-1746.2010.06285.x.CrossRefPubMed
13.
go back to reference Kinter E, Schmeding A, Rudolph I, dosReis S, Bridges J: Identifying Patient-Relevant Endpoints Among Individuals with Schizophrenia: An Application of Patient Centered Health Technology Assessment. Int J Technol Assess Health Care. 2009, 25: 35-41. 10.1017/S0266462309090059.CrossRefPubMed Kinter E, Schmeding A, Rudolph I, dosReis S, Bridges J: Identifying Patient-Relevant Endpoints Among Individuals with Schizophrenia: An Application of Patient Centered Health Technology Assessment. Int J Technol Assess Health Care. 2009, 25: 35-41. 10.1017/S0266462309090059.CrossRefPubMed
14.
go back to reference Bos W, Tarnai C: Content analysis in empirical social research. Int J Educ Res. 1999, 31: 659-671. 10.1016/S0883-0355(99)00032-4.CrossRef Bos W, Tarnai C: Content analysis in empirical social research. Int J Educ Res. 1999, 31: 659-671. 10.1016/S0883-0355(99)00032-4.CrossRef
15.
go back to reference Kracauer S: The Challenge of Qualitative Content Analysis. Public Opin Q. 1952, 16: 631-642. 10.1086/266427.CrossRef Kracauer S: The Challenge of Qualitative Content Analysis. Public Opin Q. 1952, 16: 631-642. 10.1086/266427.CrossRef
16.
go back to reference Bridges J: Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics. Appl Health Econ Health Policy. 2003, 2: 213-224.PubMed Bridges J: Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics. Appl Health Econ Health Policy. 2003, 2: 213-224.PubMed
17.
go back to reference Akkazieva B, Gulacsi L, Brandtmuller A, Pentekk M, Bridges J: Patients' Preferences for Health Care System Reform in Hungary: A Conjoint Analysis Study. Appl Health Econ Health Policy. 2006, 5: 189-198. 10.2165/00148365-200605030-00005.CrossRefPubMed Akkazieva B, Gulacsi L, Brandtmuller A, Pentekk M, Bridges J: Patients' Preferences for Health Care System Reform in Hungary: A Conjoint Analysis Study. Appl Health Econ Health Policy. 2006, 5: 189-198. 10.2165/00148365-200605030-00005.CrossRefPubMed
18.
go back to reference Farrar S, Ryan M, Ross D, Ludbrook A: Using discrete choice modelling in priority setting: an application to clinical service developments. Soc Sci Med. 2000, 50: 63-75. 10.1016/S0277-9536(99)00268-3.CrossRefPubMed Farrar S, Ryan M, Ross D, Ludbrook A: Using discrete choice modelling in priority setting: an application to clinical service developments. Soc Sci Med. 2000, 50: 63-75. 10.1016/S0277-9536(99)00268-3.CrossRefPubMed
19.
go back to reference Bridges J, Searle S, Selck F, Martinson N: Engaging families in the design of social marketing strategies for male circumcision services in Johannesburg, South Africa. Soc Mar Q. 2010, 6: 60-76.CrossRef Bridges J, Searle S, Selck F, Martinson N: Engaging families in the design of social marketing strategies for male circumcision services in Johannesburg, South Africa. Soc Mar Q. 2010, 6: 60-76.CrossRef
20.
go back to reference Ryan M, Gerard K: Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy. 2003, 2: 55-64.PubMed Ryan M, Gerard K: Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy. 2003, 2: 55-64.PubMed
21.
go back to reference Bridges J, Kinter E, Kidane L, Heinzen R, McCormick C: Things are looking up since we started listening to patients: Recent trends in the application of conjoint analysis in health 1970-2007. Patient. 2008, 1: 273-282.CrossRefPubMed Bridges J, Kinter E, Kidane L, Heinzen R, McCormick C: Things are looking up since we started listening to patients: Recent trends in the application of conjoint analysis in health 1970-2007. Patient. 2008, 1: 273-282.CrossRefPubMed
22.
go back to reference Marshall D, Bridges J, Hauber AB, Cameron R, Donnally L, Fyie K, Johnson FR: Conjoint Analysis Applications in Health-How are studies being designed and reported? An update on current practice in the published literature between 2005 and 2008. Patient. 2010, 3: 249-256.CrossRefPubMed Marshall D, Bridges J, Hauber AB, Cameron R, Donnally L, Fyie K, Johnson FR: Conjoint Analysis Applications in Health-How are studies being designed and reported? An update on current practice in the published literature between 2005 and 2008. Patient. 2010, 3: 249-256.CrossRefPubMed
23.
go back to reference Mitton C, Donaldson C: Setting priorities in Canadian regional health authorities: a survey of key decision makers. Health Policy. 2002, 60: 39-58. 10.1016/S0168-8510(01)00190-7.CrossRefPubMed Mitton C, Donaldson C: Setting priorities in Canadian regional health authorities: a survey of key decision makers. Health Policy. 2002, 60: 39-58. 10.1016/S0168-8510(01)00190-7.CrossRefPubMed
24.
go back to reference Martin DK, Pater JL, Singer PA: Priority-setting decisions for new cancer drugs: a qualitative case study. Lancet. 2001, 358: 1676-1681. 10.1016/S0140-6736(01)06714-9.CrossRefPubMed Martin DK, Pater JL, Singer PA: Priority-setting decisions for new cancer drugs: a qualitative case study. Lancet. 2001, 358: 1676-1681. 10.1016/S0140-6736(01)06714-9.CrossRefPubMed
25.
go back to reference Borbas C, Morris N, McLaughlin B, Asinger R, Gobel F: The role of clinical opinion leaders in guideline implementation and quality improvement. Chest. 2000, 118: 24S-32S. 10.1378/chest.118.2_suppl.24S.CrossRefPubMed Borbas C, Morris N, McLaughlin B, Asinger R, Gobel F: The role of clinical opinion leaders in guideline implementation and quality improvement. Chest. 2000, 118: 24S-32S. 10.1378/chest.118.2_suppl.24S.CrossRefPubMed
26.
go back to reference Greer AL: The state of the art versus the state of the science. The diffusion of new medical technologies into practice. Int J Technol Assess Health Care. 1998, 4: 5-26.CrossRef Greer AL: The state of the art versus the state of the science. The diffusion of new medical technologies into practice. Int J Technol Assess Health Care. 1998, 4: 5-26.CrossRef
27.
go back to reference Valente TW, Davis RL: Accelerating the diffusion of innovations using opinion leaders. Ann Am Acad Pol Soc Sci. 1999, 566 (1): 55-67. 10.1177/0002716299566001005.CrossRef Valente TW, Davis RL: Accelerating the diffusion of innovations using opinion leaders. Ann Am Acad Pol Soc Sci. 1999, 566 (1): 55-67. 10.1177/0002716299566001005.CrossRef
28.
go back to reference Bridges J, Gallego G, Blauvelt B: Controlling liver cancer internationally: A qualitative study of clinicians' perceptions of current public policy needs. Health Res Policy Syst. 2011, 28;9 (1): 32.CrossRef Bridges J, Gallego G, Blauvelt B: Controlling liver cancer internationally: A qualitative study of clinicians' perceptions of current public policy needs. Health Res Policy Syst. 2011, 28;9 (1): 32.CrossRef
29.
go back to reference Walsh J, Harrison JD, Young JM, Butow FN, Solomon MJ, Masya L: What are the current barriers to effective cancer care coordination? A qualitative study. BMC Health Serv Res. 2010, 10: 132-140. 10.1186/1472-6963-10-132.CrossRefPubMedPubMedCentral Walsh J, Harrison JD, Young JM, Butow FN, Solomon MJ, Masya L: What are the current barriers to effective cancer care coordination? A qualitative study. BMC Health Serv Res. 2010, 10: 132-140. 10.1186/1472-6963-10-132.CrossRefPubMedPubMedCentral
30.
go back to reference McIlfatrick S: Assessing palliative care needs: views of patients, informal carers and healthcare professionals. J Adv Nurs. 2007, 57: 77-86. 10.1111/j.1365-2648.2006.04062.x.CrossRefPubMed McIlfatrick S: Assessing palliative care needs: views of patients, informal carers and healthcare professionals. J Adv Nurs. 2007, 57: 77-86. 10.1111/j.1365-2648.2006.04062.x.CrossRefPubMed
31.
go back to reference Barbour RS: Checklists for improving rigour in qualitative research: a case of the tail wagging the dog?. BMJ. 2001, 322: 1115-1117. 10.1136/bmj.322.7294.1115.CrossRefPubMedPubMedCentral Barbour RS: Checklists for improving rigour in qualitative research: a case of the tail wagging the dog?. BMJ. 2001, 322: 1115-1117. 10.1136/bmj.322.7294.1115.CrossRefPubMedPubMedCentral
32.
go back to reference Smith JA, Flowers P, Larkin M: Interpretative Phenomenological Analysis: Theory, Method and Research. 2009, London: Sage Publications Smith JA, Flowers P, Larkin M: Interpretative Phenomenological Analysis: Theory, Method and Research. 2009, London: Sage Publications
33.
go back to reference Clark J: How to peer review a qualitative manuscript. Peer Review in Health Sciences. Edited by: Godlee F, Jefferson T. 2003, London: BMJ Books, 219-235. 2 Clark J: How to peer review a qualitative manuscript. Peer Review in Health Sciences. Edited by: Godlee F, Jefferson T. 2003, London: BMJ Books, 219-235. 2
35.
go back to reference Maxwell JA: Using Numbers in Qualitative Research. Qual Inq. 2010, 16: 475-482. 10.1177/1077800410364740.CrossRef Maxwell JA: Using Numbers in Qualitative Research. Qual Inq. 2010, 16: 475-482. 10.1177/1077800410364740.CrossRef
36.
go back to reference Sandelowski M: Real Qualitative Researchers Do Not Count: The Use of Numbers in Qualitative Research. Res Nurs Health. 2001, 24: 230-240. 10.1002/nur.1025.CrossRefPubMed Sandelowski M: Real Qualitative Researchers Do Not Count: The Use of Numbers in Qualitative Research. Res Nurs Health. 2001, 24: 230-240. 10.1002/nur.1025.CrossRefPubMed
37.
go back to reference Aguirre R, Nyerges T: Geovisual evaluation of public participation in decision making: The grapevine. J Visual Lang Comput. 2011, 22: 305-321. 10.1016/j.jvlc.2010.12.004.CrossRef Aguirre R, Nyerges T: Geovisual evaluation of public participation in decision making: The grapevine. J Visual Lang Comput. 2011, 22: 305-321. 10.1016/j.jvlc.2010.12.004.CrossRef
38.
go back to reference Arbuckle R, Atkinson MJ, Clark M, Abetz L, Lohs J, Kuhagen I, Harness J, Draelos Z, Thiboutot D, Blume-Peytavi U, Copley-Merriman K: Patient experiences with oily skin: The qualitative development of content for two new patient reported outcome questionnaires. Health Qual Life Outcomes. 2008, 6: 80-94. 10.1186/1477-7525-6-80.CrossRefPubMedPubMedCentral Arbuckle R, Atkinson MJ, Clark M, Abetz L, Lohs J, Kuhagen I, Harness J, Draelos Z, Thiboutot D, Blume-Peytavi U, Copley-Merriman K: Patient experiences with oily skin: The qualitative development of content for two new patient reported outcome questionnaires. Health Qual Life Outcomes. 2008, 6: 80-94. 10.1186/1477-7525-6-80.CrossRefPubMedPubMedCentral
39.
go back to reference Curtis JR, Wenrich MD, Carline JD, Shannon SE, Ambrozy DM, Ramsey PG: Understanding physicians' skills at providing end-of-life care: Perspectives of patients, families, and health care workers. J Gen Intern Med. 2001, 16: 41-49. 10.1111/j.1525-1497.2001.00333.x.PubMedPubMedCentral Curtis JR, Wenrich MD, Carline JD, Shannon SE, Ambrozy DM, Ramsey PG: Understanding physicians' skills at providing end-of-life care: Perspectives of patients, families, and health care workers. J Gen Intern Med. 2001, 16: 41-49. 10.1111/j.1525-1497.2001.00333.x.PubMedPubMedCentral
40.
go back to reference Hsieh H-F, Shannon SE: Three Approaches to Qualitative Content Analysis. Qual Health Res. 2005, 15: 1277-1288. 10.1177/1049732305276687.CrossRefPubMed Hsieh H-F, Shannon SE: Three Approaches to Qualitative Content Analysis. Qual Health Res. 2005, 15: 1277-1288. 10.1177/1049732305276687.CrossRefPubMed
41.
go back to reference Thurstone LL: A law of comparative judgement. Psychol Rev. 1927, 34: 273-286.CrossRef Thurstone LL: A law of comparative judgement. Psychol Rev. 1927, 34: 273-286.CrossRef
42.
go back to reference McFadden D: Conditional Logit analysis of qualitative choice behavior. Frontiers in Econometrics. Edited by: Zaremba P. 1974, New York: Academic Press, 105-142. McFadden D: Conditional Logit analysis of qualitative choice behavior. Frontiers in Econometrics. Edited by: Zaremba P. 1974, New York: Academic Press, 105-142.
43.
go back to reference Bridges J, Hauber AB, Marshall D, Lloyd A, Prosser L, Regier DA, Johnson FR, Mauskopf J: A Checklist for Conjoint Analysis Applications in Health: Report of the ISPOR Conjoint Analysis Good Research Practices Taskforce. Value Health. 14: 403-413. Bridges J, Hauber AB, Marshall D, Lloyd A, Prosser L, Regier DA, Johnson FR, Mauskopf J: A Checklist for Conjoint Analysis Applications in Health: Report of the ISPOR Conjoint Analysis Good Research Practices Taskforce. Value Health. 14: 403-413.
44.
go back to reference Langenhoff BS, Krabbe PF, Ruers TJ: Computer-based decision making in medicine: A model for surgery of colorectal liver metastases. Eur J Surg Oncol. 2007, 33 (Suppl 2): S111-7.CrossRefPubMed Langenhoff BS, Krabbe PF, Ruers TJ: Computer-based decision making in medicine: A model for surgery of colorectal liver metastases. Eur J Surg Oncol. 2007, 33 (Suppl 2): S111-7.CrossRefPubMed
45.
go back to reference Fraenkel L, Chodkowski D, Lim J, Garcia-Tsao G: Patients' preferences for treatment of hepatitis C. Med Decis Making. 2010, 30: 45-57. 10.1177/0272989X09341588.CrossRefPubMed Fraenkel L, Chodkowski D, Lim J, Garcia-Tsao G: Patients' preferences for treatment of hepatitis C. Med Decis Making. 2010, 30: 45-57. 10.1177/0272989X09341588.CrossRefPubMed
46.
go back to reference Nathan H, Bridges JF, Schulick RD, Cameron AM, Hirose K, Edil BH, et al: Understanding Surgical Decision Making in Early Hepatocellular Carcinoma. J Clin Oncol. 2011, 29: 619-625. 10.1200/JCO.2010.30.8650.CrossRefPubMedPubMedCentral Nathan H, Bridges JF, Schulick RD, Cameron AM, Hirose K, Edil BH, et al: Understanding Surgical Decision Making in Early Hepatocellular Carcinoma. J Clin Oncol. 2011, 29: 619-625. 10.1200/JCO.2010.30.8650.CrossRefPubMedPubMedCentral
47.
go back to reference Louviere J, Woodworth G: Source Design and Analysis of Simulated Consumer Choice or Allocation Experiments: An Approach Based on Aggregate Data. J Mark Res. 1983, 20: 350-367. 10.2307/3151440.CrossRef Louviere J, Woodworth G: Source Design and Analysis of Simulated Consumer Choice or Allocation Experiments: An Approach Based on Aggregate Data. J Mark Res. 1983, 20: 350-367. 10.2307/3151440.CrossRef
49.
go back to reference Huber J, Zwerina K: The Importance of Utility Balance in Efficient Choice Designs. J Mark Res. 1996, 33: 307-317. 10.2307/3152127.CrossRef Huber J, Zwerina K: The Importance of Utility Balance in Efficient Choice Designs. J Mark Res. 1996, 33: 307-317. 10.2307/3152127.CrossRef
50.
go back to reference Huber P: The Behavior of Maximum Likelihood Estimates Under Nonstandard Conditions. Proceedings of the Fifth Berkeley Symposium in Mathematical Statistics. 1967, Berkeley: University of California Press, 1. Huber P: The Behavior of Maximum Likelihood Estimates Under Nonstandard Conditions. Proceedings of the Fifth Berkeley Symposium in Mathematical Statistics. 1967, Berkeley: University of California Press, 1.
51.
go back to reference White H: A Heteroskedasticity-consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity. Econometrica. 1980, 48: 817-838. 10.2307/1912934.CrossRef White H: A Heteroskedasticity-consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity. Econometrica. 1980, 48: 817-838. 10.2307/1912934.CrossRef
52.
go back to reference Bridges J, Selck F, Gray G, McIntyre J, Martinson N: Condom avoidance and determinants of demand for male circumcision in Johannesburg, South Africa. Health Policy Plan. 2011, 26: 298-306. 10.1093/heapol/czq064.CrossRefPubMed Bridges J, Selck F, Gray G, McIntyre J, Martinson N: Condom avoidance and determinants of demand for male circumcision in Johannesburg, South Africa. Health Policy Plan. 2011, 26: 298-306. 10.1093/heapol/czq064.CrossRefPubMed
53.
go back to reference Spearman C: The proof and measurement of association between two things. Am J Psychol. 1904, 15: 72-101. 10.2307/1412159.CrossRef Spearman C: The proof and measurement of association between two things. Am J Psychol. 1904, 15: 72-101. 10.2307/1412159.CrossRef
54.
go back to reference FitzSimons DW: Prevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe. Vaccine. 2008, 26: 5669-5674. 10.1016/j.vaccine.2008.08.023.CrossRefPubMed FitzSimons DW: Prevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe. Vaccine. 2008, 26: 5669-5674. 10.1016/j.vaccine.2008.08.023.CrossRefPubMed
55.
go back to reference Noda I, Kitamoto M, Nakahara H, Hayashi R, Okimoto T, Monzen Y, Yamada H, Imagawa M, Hiraga N, Tanaka J, Chayama K: Regular surveillance by imaging for early detection and better prognosis of hepatocellular carcinoma in patients infected with hepatitis C virus. J Gastroenterol. 2010, 45: 105-112. 10.1007/s00535-009-0131-x.CrossRefPubMed Noda I, Kitamoto M, Nakahara H, Hayashi R, Okimoto T, Monzen Y, Yamada H, Imagawa M, Hiraga N, Tanaka J, Chayama K: Regular surveillance by imaging for early detection and better prognosis of hepatocellular carcinoma in patients infected with hepatitis C virus. J Gastroenterol. 2010, 45: 105-112. 10.1007/s00535-009-0131-x.CrossRefPubMed
56.
go back to reference Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J: Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from Japan. Clin Gastroenterol Hepatol. 2006, 4: 1170-1176. 10.1016/j.cgh.2006.06.007.CrossRefPubMed Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J: Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from Japan. Clin Gastroenterol Hepatol. 2006, 4: 1170-1176. 10.1016/j.cgh.2006.06.007.CrossRefPubMed
57.
go back to reference Marrero JA: Hepatocellular carcinoma. Curr Opin Gastroenterol. 2005, 21: 308-312. 10.1097/01.mog.0000159817.55661.ca.CrossRefPubMed Marrero JA: Hepatocellular carcinoma. Curr Opin Gastroenterol. 2005, 21: 308-312. 10.1097/01.mog.0000159817.55661.ca.CrossRefPubMed
58.
go back to reference Ando E, Kuromatsu R, Tanaka M, Takada A, Fukushima N, Sumie S, Nagaoka S, Akiyoshi J, Inoue K, Torimura T, Kumashiro R, Ueno T, Sata M: Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease. J Clin Gastroenterol. 2006, 40: 942-948. 10.1097/01.mcg.0000225675.14594.d6.CrossRefPubMed Ando E, Kuromatsu R, Tanaka M, Takada A, Fukushima N, Sumie S, Nagaoka S, Akiyoshi J, Inoue K, Torimura T, Kumashiro R, Ueno T, Sata M: Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease. J Clin Gastroenterol. 2006, 40: 942-948. 10.1097/01.mcg.0000225675.14594.d6.CrossRefPubMed
59.
go back to reference Lesmana LA, Leung N, Mahachai V, Phiet PH, Suh DJ, Yao G, Zhuang H: Hepatitis B: Overview of the burden of disease in the Asia-Pacific region. Liver Int. 2006, 26 (Suppl 2): 3-10.CrossRef Lesmana LA, Leung N, Mahachai V, Phiet PH, Suh DJ, Yao G, Zhuang H: Hepatitis B: Overview of the burden of disease in the Asia-Pacific region. Liver Int. 2006, 26 (Suppl 2): 3-10.CrossRef
60.
go back to reference Lai ECH, Lau WY: The continuing challenge of hepatic cancer in Asia. Surgeon. 2005, 3: 210-215. 10.1016/S1479-666X(05)80043-5.CrossRefPubMed Lai ECH, Lau WY: The continuing challenge of hepatic cancer in Asia. Surgeon. 2005, 3: 210-215. 10.1016/S1479-666X(05)80043-5.CrossRefPubMed
61.
go back to reference Song P, Tang W, Tamura S, Hasegawa K, Sugawara Y, Dong J, Kokudo N: The management of hepatocellular carcinoma in Asia: a guideline combining quantitative and qualitative evaluation. Biosci Trends. 2010, 4: 283-287.PubMed Song P, Tang W, Tamura S, Hasegawa K, Sugawara Y, Dong J, Kokudo N: The management of hepatocellular carcinoma in Asia: a guideline combining quantitative and qualitative evaluation. Biosci Trends. 2010, 4: 283-287.PubMed
62.
go back to reference Chien Y-C, Jan C-F, Kuo H-S, Chen C-J: Nationwide Hepatitis B Vaccination Program in Taiwan: Effectiveness in the 20 Years After It Was Launched. Epidemiol Rev. 2006, 28: 126-135. 10.1093/epirev/mxj010.CrossRefPubMed Chien Y-C, Jan C-F, Kuo H-S, Chen C-J: Nationwide Hepatitis B Vaccination Program in Taiwan: Effectiveness in the 20 Years After It Was Launched. Epidemiol Rev. 2006, 28: 126-135. 10.1093/epirev/mxj010.CrossRefPubMed
63.
go back to reference Moore MA, Manan AA, Chow KY, Cornain SF, Devi CR, Triningsih FX, Laudico A, Mapua CA, Mirasol-Lumague MR, Noorwati S, Nyunt K, Othman NH, Shah SA, Sinuraya ES, Yip CH, Sobue T: Cancer epidemiology and control in peninsular and island South-East Asia-past, present and future. Asian Pac J Cancer Prev. 2010, 11 (Suppl 2): 81-98.PubMed Moore MA, Manan AA, Chow KY, Cornain SF, Devi CR, Triningsih FX, Laudico A, Mapua CA, Mirasol-Lumague MR, Noorwati S, Nyunt K, Othman NH, Shah SA, Sinuraya ES, Yip CH, Sobue T: Cancer epidemiology and control in peninsular and island South-East Asia-past, present and future. Asian Pac J Cancer Prev. 2010, 11 (Suppl 2): 81-98.PubMed
64.
go back to reference WHO: Progress towards meeting the 2012 hepatitis B control milestone: WHO Western Pacific Region. Wkly Epidemiol Rec. 2011, 86: 180-188. WHO: Progress towards meeting the 2012 hepatitis B control milestone: WHO Western Pacific Region. Wkly Epidemiol Rec. 2011, 86: 180-188.
65.
go back to reference Ham C, Coulter A: Explicit and implicit rationing: taking responsibility and avoiding blame for health care choices. J Health Serv Res Policy. 2001, 6: 163-169. 10.1258/1355819011927422.CrossRefPubMed Ham C, Coulter A: Explicit and implicit rationing: taking responsibility and avoiding blame for health care choices. J Health Serv Res Policy. 2001, 6: 163-169. 10.1258/1355819011927422.CrossRefPubMed
66.
go back to reference Neiger BL, Thackeray R, Fagen MC: Basic priority rating model 2.0: current applications for priority setting in health promotion practice. Health Promot Pract. 2011, 12: 166-171. 10.1177/1524839910393281.CrossRefPubMed Neiger BL, Thackeray R, Fagen MC: Basic priority rating model 2.0: current applications for priority setting in health promotion practice. Health Promot Pract. 2011, 12: 166-171. 10.1177/1524839910393281.CrossRefPubMed
67.
go back to reference Mitton C, Patten S: Evidence-based priority-setting: what do the decision-makers think?. J Health Serv Res Policy. 2004, 9: 146-152. 10.1258/1355819041403240.CrossRefPubMed Mitton C, Patten S: Evidence-based priority-setting: what do the decision-makers think?. J Health Serv Res Policy. 2004, 9: 146-152. 10.1258/1355819041403240.CrossRefPubMed
68.
go back to reference Viergever RF, Olifson S, Ghaffar A, Terry RF: A checklist for health research priority setting: nine common themes of good practice. Health Res Policy Syst. 2010, 8: 36-44.CrossRefPubMedPubMedCentral Viergever RF, Olifson S, Ghaffar A, Terry RF: A checklist for health research priority setting: nine common themes of good practice. Health Res Policy Syst. 2010, 8: 36-44.CrossRefPubMedPubMedCentral
69.
go back to reference Schwarzinger M, Mohamed MK, Gad RR, Dewedar S, Fontanet A, Carrat F, et al: Risk perception and priority setting for intervention among hepatitis C virus and environmental risks: a cross-sectional survey in the Cairo community. BMC Public Health. 2010, 10: 773-782. 10.1186/1471-2458-10-773.CrossRefPubMedPubMedCentral Schwarzinger M, Mohamed MK, Gad RR, Dewedar S, Fontanet A, Carrat F, et al: Risk perception and priority setting for intervention among hepatitis C virus and environmental risks: a cross-sectional survey in the Cairo community. BMC Public Health. 2010, 10: 773-782. 10.1186/1471-2458-10-773.CrossRefPubMedPubMedCentral
Metadata
Title
Identifying and prioritizing strategies for comprehensive liver cancer control in Asia
Authors
John FP Bridges
Gisselle Gallego
Masatoshi Kudo
Kiwamu Okita
Kwang-Hyub Han
Sheng-Long Ye
Barri M Blauvelt
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2011
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-11-298

Other articles of this Issue 1/2011

BMC Health Services Research 1/2011 Go to the issue